Introduction Nondilated left ventricular cardiomyopathy (NDLVC) challenges clinicians with a condition that can silently advance despite a normal-sized heart. A large multicenter analysis reported in the Canadian Journal of Cardiology found that nearly 40% of patients experienced clinically meaningful disease progression over long-term follow-up. This finding underscores the importance of identifying predictive biomarkers that can…